2.3 Hemoglobinopathies & Qualitative Globin Chain Defects

Hemoglobinopathies & Qualitative Globin Chain Defects

Qualitative hemoglobinopathies are inherited genetic disorders caused by point mutations, deletions, or insertions in globin genes that alter the structural amino acid sequence of a globin chain. Unlike quantitative thalassemias, which involve reduced synthesis of structurally normal chains, qualitative hemoglobin variants synthesize structurally abnormal hemoglobin tetramers. The vast majority of clinically significant variants involve the $\beta$-globin gene (HBB) located on chromosome 11p15.4.

---

Normal Adult vs. Variant Globin Architecture

Normal post-neonatal human erythrocytes contain three physiological hemoglobin species:

• Hemoglobin A ($HbA = \alpha_2\beta_2$): Represents 95–98% of total adult hemoglobin.
• Hemoglobin $A_2$ ($HbA_2 = \alpha_2\delta_2$): Represents 1.5–3.5% of total adult hemoglobin.
• Fetal Hemoglobin ($HbF = \alpha_2\gamma_2$): Represents <1.0–2.0% of total adult hemoglobin.

Normal Adult Hemoglobins:                  Major Qualitative Beta-Chain Variants:
┌──────────────────────────────────────┐   ┌──────────────────────────────────────────────┐
│ Hb A  (α₂β₂)   : 95 - 98%            │   │ Hb S: β6 Glu ──► Val (Hydrophobic Point Mut) │
│ Hb A₂ (α₂δ₂)   : 1.5 - 3.5%          │   │ Hb C: β6 Glu ──► Lys (Positively Charged)    │
│ Hb F  (α₂γ₂)   : < 1.0%              │   │ Hb E: β26 Glu ──► Lys (Splice Site Defect)   │
└──────────────────────────────────────┘   └──────────────────────────────────────────────┘

---

Sickle Cell Anemia (Homozygous Hb SS)

Molecular Genetics & Pathophysiology of Polymerization

Sickle Cell Anemia (Hb SS) results from a single base point mutation in the sixth codon of the $\beta$-globin gene (HBB): GAG $\rightarrow$ GTG, replacing a negatively charged, hydrophilic glutamic acid with a nonpolar, hydrophobic valine at position 6 of the $\beta$-globin polypeptide chain (designated $\beta^6\text{Glu}\rightarrow\text{Val}$ or $\beta^S$).

1. Deoxygenation & Nucleation: When arterial blood unloads oxygen in hypoxic capillary beds, deoxy-HbS exposes the hydrophobic valine at position $\beta_1 6$. This valine slots into a complementary hydrophobic receptor pocket (formed by phenylalanine 85 and leucine 88) on the $\beta_2$ chain of an adjacent deoxy-HbS tetramer.
2. Polymerization: Deoxy-HbS tetramers aggregate into long, rigid, 14-strand helical fibrous polymers (tactoids). These bundles distort the erythrocyte cytoskeleton from a flexible biconcave disc into an elongated, rigid, crescentic sickle cell (drepanocyte).
3. Reversibility vs. Irreversibility: Initial sickling cycles are reversible upon re-oxygenation. However, repeated sickling-unsickling cycles induce continuous membrane shearing, calcium influx, potassium and water efflux (cellular dehydration via the Gardos channel), and spectrin cross-linking. This converts cells into irreversibly sickled cells (ISCs) that remain rigid even under 100% oxygen saturation.

[Deoxygenation / Acidosis / Dehydration]
                 │
                 ▼
[Hydrophobic β6 Valine Exposed]
                 │
                 ▼
[14-Strand Helical Tactoid Polymerization]
                 │
                 ▼
   [Rigid Sickle Cell Formation]
                 │
         ┌───────┴───────────────────────┐
         ▼                               ▼
[Microvascular Vaso-Occlusion]    [Premature Extravascular & Intravascular
 • Acute Chest Syndrome                 Hemolysis (RBC Lifespan 10-20 days)]
 • Dactylitis / Bone Pain                • Jaundice, Gallstones, ↑ Indirect Bili
 • Splenic Infarctions ──► Autosplenectomy

Clinical Complications

• Vaso-Occlusive Crises (VOC): Microvascular plugging in bones, joints, and viscera causing severe ischemic pain; dactylitis ("hand-foot syndrome") in infants.
• Acute Chest Syndrome (ACS): The leading cause of mortality in Hb SS; characterized by new pulmonary infiltrates on chest X-ray, chest pain, fever, tachypnea, and profound arterial hypoxia.
• Aplastic Crisis: Sudden, temporary cessation of bone marrow erythropoiesis caused by infection with Human Parvovirus B19, which selectively infects and lyses erythroid progenitor cells (pronormoblasts). Hemoglobin drops precipitously with a reticulocytopenia ($<1%$).
• Autosplenectomy: Repeated vaso-occlusion and micro-infarctions during early childhood cause progressive splenic fibrosis, calcification, and atrophy, leaving a non-functional remnant by age 5–8. Loss of splenic phagocytosis leaves patients highly susceptible to encapsulated bacteria (Streptococcus pneumoniae, Haemophilus influenzae, Salmonella osteomyelitis).

Peripheral Smear Morphology

• Classic drepanocytes (sickle cells): Elongated, slender crescents with sharp, pointed ends.
• Abundant target cells (codocytes) and polychromasia (reticulocyte count 8–20%).
• Howell-Jolly bodies (small, round, purple DNA nuclear remnants) and Pappenheimer bodies, reflecting loss of splenic pitting function (hyposplenism/autosplenectomy).
• Nucleated red blood cells (NRBCs) reflecting intense marrow erythroid hyperplasia.

---

Sickle Cell Trait (Heterozygous Hb AS)

Sickle Cell Trait is the benign heterozygous carrier state characterized by inheritance of one normal $\beta^A$ gene and one mutant $\beta^S$ gene (genotype $\beta^A/\beta^S$). Red blood cells contain 55–65% Hb A, 35–45% Hb S, and normal levels of $HbA_2$ and $HbF$. (Normal $\beta^A$ globin chains have a higher affinity for $\alpha$ chains than $\beta^S$, ensuring that Hb A synthesis always exceeds Hb S).

• Clinical Picture: Individuals are completely asymptomatic under normal physiological conditions with normal life expectancy, normal complete blood count indices, and normal erythrocyte lifespan.
• Smear Morphology: Completely normal peripheral blood smear; sickle cells and target cells are absent under baseline conditions.
• Renal Complications: Under conditions of extreme hypoxia, hyperosmolarity, and acidosis inside the renal medulla, sickling can occur within the vasa recta, causing micro-infarctions that manifest as painless hematuria or hyposthenuria (inability to concentrate urine, leading to isosthenuria).

---

Hemoglobin C Disease (Hb CC) & Trait (Hb AC)

Hemoglobin C is caused by a point mutation at codon 6 of the $\beta$-globin gene: GAG $\rightarrow$ AAG, substituting a negatively charged glutamic acid with a positively charged lysine (designated $\beta^6\text{Glu}\rightarrow\text{Lys}$ or $\beta^C$).

Hb C Hexagonal Crystal Formation (Hb CC):
┌────────────────────────────────────────┐
│   Hexagonal / Tetragonal 'Bar of Gold' │
│   Dense Intracellular Rod Crystal      │
│   Surrounded by Clear Membrane Zone    │
└────────────────────────────────────────┘

Hemoglobin C Disease (Homozygous Hb CC)

• Pathophysiology: Hb C has low solubility in aqueous solution and tends to precipitate into dense, rigid, intracellular hexagonal or tetragonal crystals under oxygenated, dehydrated conditions. This promotes cellular rigidity and splenic sequestration, causing a mild-to-moderate chronic hemolytic anemia (Hb 9–12 g/dL).
• Morphology:
  • Hb C Crystals: Diagnostic, elongated, dark-staining hexagonal/rod-shaped crystals ("bars of gold" or "coffin lids") enclosed within a visible clear zone of empty red cell membrane.
  • Marked target cells (codocytes), often comprising 40% to 90% of all circulating erythrocytes.
  • Folded cells ("pocketbook" or "clam-shell" cells) and microspherocytes.
• Electrophoresis / HPLC: >90% Hb C, <7% Hb F, 0% Hb A.

Hemoglobin C Trait (Heterozygous Hb AC)

• Asymptomatic carrier state ($\beta^A/\beta^C$). Clinically silent with normal RBC lifespan.
• Smear demonstrates moderate numbers of target cells (20–40%); crystals are absent.
• Electrophoresis reveals ~60% Hb A and ~40% Hb C.

---

Hemoglobin SC Disease (Double Heterozygous Hb SC)

Hemoglobin SC disease occurs when an individual inherits one $\beta^S$ allele from one parent and one $\beta^C$ allele from the other (genotype $\beta^S/\beta^C$). No normal $\beta^A$ chains are synthesized.

• Pathophysiology: Intracellular Hb C accelerates potassium and water loss via the erythrocyte K-Cl cotransporter, producing marked cellular dehydration. This raises the mean corpuscular hemoglobin concentration of Hb S, drastically shortening the delay time for Hb S polymerization. Although clinical severity is generally intermediate between Hb SS and Hb AS, patients experience significant vaso-occlusive crises and have a notably higher incidence of proliferative sickle retinopathy and avascular necrosis of the femoral and humeral heads.
• Smear Morphology & Hb SC Crystals:
  • Characteristic "Hb SC crystals": Unique crystalline aggregates described as "glove-shaped", "biscornu", or resembling the "Washington Monument", featuring finger-like or angled crystalline projections protruding from the cell membrane.
  • Abundant target cells, folded cells, and occasional classic sickle cells.
• Electrophoresis / HPLC: Approximately 50% Hb S and 50% Hb C (typically 45–48% Hb S, 45–48% Hb C, 1–5% Hb F, and 0% Hb A).

---

Hemoglobin E (Hb E)

Hemoglobin E results from a point mutation in codon 26 of the $\beta$-globin gene: GAG $\rightarrow$ AAG, substituting a glutamic acid with a lysine (designated $\beta^{26}\text{Glu}\rightarrow\text{Lys}$ or $\beta^E$).

• Mechanism: In addition to altering the amino acid sequence, this point mutation activates an alternate "cryptic" mRNA splice site within exon 1, leading to abnormal splicing and reduced overall $\beta^E$ chain production. Hb E therefore exhibits characteristics of both a structural hemoglobinopathy and a mild $\beta$-thalassemia.
• Prevalence: The second most common hemoglobin variant globally, exceptionally prevalent in Southeast Asia (Thailand, Cambodia, Laos, Myanmar), where carrier frequency exceeds 30–50%.
• Clinical & Laboratory Features: Homozygous Hb EE presents with mild microcytic hypochromic anemia (MCV 65–75 fL) and abundant target cells. Heterozygous Hb AE is asymptomatic with borderline microcytosis. Crucially, on alkaline electrophoresis, Hb E co-migrates with Hb $A_2$ and Hb C.

---

Laboratory Diagnostic Identification Methods

                         Laboratory Diagnostic Workflow
                                  Whole Blood
                                       │
                     ┌─────────────────┴─────────────────┐
                     ▼                                   ▼
          [Tube Solubility Test]              [Alkaline Electrophoresis]
          (Sodium Dithionite)                     (Cellulose Acetate, pH 8.4-8.6)
          • Turbid: Insoluble Hb S/SC/AS          • Order: (+) A ─ F ─ S ─ C (-)
          • Clear : Soluble Hb A/F/C              • Mnemonic: 'A Fat Santa Claus'
                     │                                   │
                     └─────────────────┬─────────────────┘
                                       ▼
                          [Acid Agar Electrophoresis]
                            (Citrate Agar, pH 6.0-6.2)
                          • Order: (+) F ─ A ─ S ─ C (-)
                          • Confirms S vs D/G & C vs E/A₂
                                       │
                                       ▼
                         [Confirmatory Cation-Exchange HPLC]
                          • Quantitative Retention Times (min)

1. Sickling Solubility Test (Sodium Dithionite / Tube Turbidity Assay)

• Principle: Whole blood is mixed with a reagent containing a lysing detergent (saponin) and a strong reducing agent (sodium dithionite) in a high-molarity phosphate buffer. Saponin lyses erythrocytes, releasing hemoglobin. Sodium dithionite deoxygenates the hemoglobin tetramers. Deoxygenated Hb S is insoluble in concentrated phosphate buffer and precipitates into a liquid-crystal suspension that scatters light, producing a turbid, opaque solution through which bold black lines on a background reader card cannot be visualized. Soluble hemoglobins (Hb A, Hb F, Hb C) remain in solution, leaving a transparent, clear red liquid.
• Critical Limitations:
  • Does NOT distinguish between Sickle Cell Anemia (Hb SS), Sickle Cell Trait (Hb AS), or Hemoglobin SC disease (Hb SC)—all test positive!
• Interferences & False Results:
  • False-Positive Causes: Hypergammaglobulinemia (multiple myeloma, Waldenström macroglobulinemia, where plasma proteins precipitate in phosphate buffer), extreme erythrocytosis (blood Hb > 18 g/dL), severe hyperlipidemia/lipemia, Heinz bodies, and rare non-S sickling variants (e.g., Hb C-Harlem / Hb C-Georgetown).
  • False-Negative Causes: Infants under 6 months of age (fetal hemoglobin comprises >80% of total hemoglobin, so Hb S concentration is below the test's ~15–20% sensitivity threshold), severe anemia (Hb < 7.0 g/dL; requires doubling the blood sample volume), or recent transfusion with normal Hb AA blood.

2. Cellulose Acetate Electrophoresis (Alkaline pH 8.4–8.6)

At alkaline pH (8.4–8.6), hemoglobin molecules possess an overall net negative electrical charge and migrate toward the positive electrode (anode, +).

• Migration Order from Anode (+) to Cathode (-): $\text{Anode (+)} \longrightarrow \mathbf{Hb\ A} \longrightarrow \mathbf{Hb\ F} \longrightarrow \mathbf{Hb\ S\ (D,\ G)} \longrightarrow \mathbf{Hb\ C\ (A_2,\ E,\ O\text{-Arab})} \longrightarrow \text{Cathode (-)}$
• Standard Mnemonics: "A Fat Santa Claus" (A, F, S, C from fast/anodal to slow/cathodal) or Crawl, Slow, Fast, Accelerate (C, S, F, A from cathode to anode).
• Diagnostic Co-migrations:
  • The S position contains: Hb S, Hb D (D-Los Angeles/Punjab), and Hb G.
  • The C position contains: Hb C, Hb $A_2$, Hb E, and Hb O-Arab.
  • Note: Hb H and Hb Barts are fast-migrating variants that migrate anodally beyond Hb A.
  • Because variants co-migrate at alkaline pH, alkaline electrophoresis alone is never diagnostic and must be paired with acid electrophoresis or HPLC.

3. Citrate Agar Electrophoresis (Acid pH 6.0–6.2)

At acid pH (6.0–6.2), agar contains sulfated agaropectin that binds reversibly to specific surface residues on hemoglobin tetramers based on their molecular conformation rather than net electrical charge.

• Migration Order from Anode (+) to Cathode (-): $\text{Anode (+)} \longrightarrow \mathbf{Hb\ F} \longrightarrow \mathbf{Hb\ A\ (A_2,\ D,\ E,\ G)} \longrightarrow \mathbf{Hb\ S} \longrightarrow \mathbf{Hb\ C} \longrightarrow \text{Cathode (-)}$
• Key Diagnostic Separations:
  • Separates Hb S from Hb D and Hb G: Hb S migrates toward the cathode, whereas Hb D and Hb G migrate with Hb A.
  • Separates Hb C from Hb $A_2$ and Hb E: Hb C migrates farthest toward the cathode, whereas Hb $A_2$ and Hb E migrate with Hb A.

4. High-Performance Liquid Chromatography (HPLC) & Capillary Electrophoresis

• Cation-Exchange HPLC: Automated reference method that separates hemoglobin fractions based on charge interactions with a silica column under an increasing ionic strength gradient. Each variant elutes at a characteristic retention time (RT): Hb $A_{1c}$ (2.0 min), Hb F (1.1–1.3 min), Hb $A_2$ (3.6–3.8 min), Hb S (4.4–4.6 min), and Hb C (5.0–5.2 min). Provides precise quantitative measurement of Hb $A_2$ and Hb F.
• Capillary Electrophoresis (CE): Utilizes high-voltage separation in narrow silica capillaries at alkaline pH, offering superior resolution that cleanly separates Hb $A_2$ from Hb E and Hb C.

---

Comprehensive Hemoglobin Variant Reference Matrix